Notice for atrasentan (Novartis Pharmaceuticals Australia Pty Ltd)
Active ingredients
atrasentan
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
film-coated tablets
Indication
Treatment of primary IgA nephropathy
Therapeutic area
Nephrology